South & Central America Lung Cancer Screening Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 – Regional Analysis– by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

No. of Pages: 100    |    Report Code: BMIRE00029065    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Lung Cancer Screening Market

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America Lung Cancer Screening Market – by Technology

1.3.2        South & Central America Lung Cancer Screening Market – by Cancer Type

1.3.3        South & Central America Lung Cancer Screening Market – by Age Group

1.3.4        South & Central America Lung Cancer Screening Market – by End User

1.3.5        South & Central America Lung Cancer Screening Market – by Country

2.           South & Central America Lung Cancer Screening Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South & Central America Lung Cancer Screening Market – Market Landscape

4.1         Overview

4.2         South & Central America PEST Analysis

4.3         Expert’s Opinion

5.           South & Central America Lung Cancer Screening Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Lung Cancer Incidences

5.2         Market Restraints

5.2.1        High Cost of Lung Cancer Screening Tests

5.3         Market Opportunities

5.3.1        Collaboration with Regional Hospitals and Clinics

5.4         Future Trends

5.4.1        Use of Cutting-Edge Technologies

5.5         Impact Analysis

6.           Lung Cancer Screening Market – South & Central America Analysis

6.1         South & Central America Lung Cancer Screening Market Revenue Forecast and Analysis

7.           South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2028 – By Cancer Type

7.1         Overview

7.2         South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

7.3         Non–Small Cell Lung Cancer (NSCLC)

7.3.1        Overview

7.3.2        Non–Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030  (US$ Mn)

7.4         Small Cell Lung Cancer

7.4.1        Overview

7.4.2        Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.           South & Central America Lung Cancer Screening Market Analysis – by Technology

8.1         Overview

8.2         Low-Dose Computed Tomography (LDCT)

8.2.1        Overview

8.2.2        Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.3         Chest X-ray

8.3.1        Overview

8.3.2        Chest X-ray: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.4         Liquid Biopsy

8.4.1        Overview

8.4.2        Liquid Biopsy: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

9.           South & Central America Lung Cancer Screening Market Analysis – by Age Group

9.1         Overview

9.2 & Older

9.2.1        Overview

9.2.2 & Older: South & Central America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

9.3         Below 50

9.3.1        Overview

9.3.2        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.        South & Central America Lung Cancer Screening Market Analysis – by End User

10.1      Overview

10.2      Hospitals

10.2.1     Overview

10.2.2     Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.3      Diagnostic Centers

10.3.1     Overview

10.3.2     Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.4      Others

10.4.1     Overview

10.4.2     Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

11.        South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2028 – Country Analysis

11.1      South & Central America Lung Cancer Screening Market Overview

11.1.1.1       Brazil: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       Brazil: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.3       Brazil: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.1.4       Brazil: South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.5       Brazil: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.1.6       Brazil: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.2       Argentina: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Argentina: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.3       Argentina: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.2.4       Argentina: South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.5       Argentina: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.2.6       Argentina: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.3       Rest of South & Central America: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       Rest of South & Central America: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.3       Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.3.4       Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.5       Rest of South & Central America: South & Central America Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.3.6       Rest of South & Central America: South & Central America Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12.        South & Central America Lung Cancer Screening Market–Industry Landscape

12.1      Recent Growth Strategies

12.1.1     Overview

13.        Company Profiles

13.1      Nuance Communications Inc

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GE HealthCare

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Medtronic

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Canon Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Koninklijke Philips NV

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Siemens AG

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Brazil South & Central America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 2.             Brazil South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 3.             Brazil South & Central America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 4.             Brazil South & Central America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 5.             Argentina South & Central America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 6.             Argentina South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 7.             Argentina South & Central America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 8.             Argentina South & Central America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 9.             Rest of South & Central America Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 10.          Rest of South & Central America Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 11.          Rest of South & Central America Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 12.          Rest of South & Central America Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13.          Recent Growth Strategies in the South & Central America Lung Cancer Screening Market

Table 14.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           South & Central America Lung Cancer Screening Market Segmentation

Figure 2.           South & Central America Lung Cancer Screening Market, by Country

Figure 3.           South & Central America Lung Cancer Screening Market Overview

Figure 4.           Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in South & Central America Lung Cancer Screening Market

Figure 5.           South & Central America Expected to Show Remarkable Growth During Forecast Period

Figure 6.           South & Central America: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           South & Central America Lung Cancer Screening Market Impact Analysis of Driver and Restraints

Figure 9.           South & Central America Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020-2030

Figure 10.        South & Central America Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

Figure 11.        Non–Small Cell Lung Cancer (NSCLC): South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030  (US$ Million)

Figure 12.        Small Cell Lung Cancer: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        South & Central America Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)

Figure 14.        Low-Dose Computed Tomography (LDCT): South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030  (US$ Million)

Figure 15.        Chest X-ray: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Liquid Biopsy: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Others: South & Central America Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 18.        South & Central America Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)

Figure 19. & Older: South & Central America Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        South & Central America Lung Cancer Screening Market, by End User, 2022 & 2030 (%)

Figure 22.        Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        South & Central America Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Mn)

Figure 26.        South & Central America Lung Cancer Screening Market Revenue Share, by Key Country (2022 and 2030)

Figure 27.        Brazil: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 28.        Argentina: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        Rest of South & Central America: South & Central America Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

The List of Companies - South & Central America Lung Cancer Screening Market

  1. GE HealthCare Technologies Inc
  2. Medtronic Plc
  3. Canon Medical Systems Corp
  4. Koninklijke Philips NV
  5. Siemens AG